Cochrane Abstracts
Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Atovaquone‐proguanil for Treating Uncomplicated Plasmodium Falciparum Malaria." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431029/all/Atovaquone‐proguanil_for_treating_uncomplicated_Plasmodium_falciparum_malaria.
Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431029/all/Atovaquone‐proguanil_for_treating_uncomplicated_Plasmodium_falciparum_malaria. Accessed April 19, 2025.
Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431029/all/Atovaquone‐proguanil_for_treating_uncomplicated_Plasmodium_falciparum_malaria
Atovaquone‐proguanil for Treating Uncomplicated Plasmodium Falciparum Malaria [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431029/all/Atovaquone‐proguanil_for_treating_uncomplicated_Plasmodium_falciparum_malaria.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria
ID - 431029
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431029/all/Atovaquone‐proguanil_for_treating_uncomplicated_Plasmodium_falciparum_malaria
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
